(FVAL) Fidelity Value Factor - Overview
Etf: Stocks, Large-Cap, Mid-Cap, US
Dividends
| Dividend Yield | 1.75% |
| Yield on Cost 5y | 2.97% |
| Yield CAGR 5y | 12.28% |
| Payout Consistency | 99.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.2% |
| Relative Tail Risk | 2.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.80 |
| Alpha | 3.90 |
| Character TTM | |
|---|---|
| Beta | 0.927 |
| Beta Downside | 0.946 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.39% |
| CAGR/Max DD | 1.02 |
Description: FVAL Fidelity Value Factor January 20, 2026
The Fidelity® Value Factor ETF (FVAL) allocates at least 80% of its assets to stocks that track the Fidelity U.S. Value Factor Index, which targets large- and mid-cap U.S. companies judged to be undervalued based on metrics such as low price-to-earnings and price-to-book ratios. The fund may also generate ancillary income by lending securities.
Key metrics as of the latest filing: expense ratio ≈ 0.25%, dividend yield ≈ 2.1% annualized, and a weighted average market cap of roughly $30 billion, indicating a tilt toward established firms. The top sector exposures are Financials (≈ 22%), Consumer Staples (≈ 18%), and Health Care (≈ 15%), sectors that historically benefit from a low-interest-rate environment and steady cash flows. Performance tends to be positively correlated with a widening value premium and negatively impacted by rapid interest-rate hikes that compress earnings multiples.
For a deeper, data-driven view of how FVAL fits within a value-focused portfolio, you might explore the analytics on ValueRay.
What is the price of FVAL shares?
Over the past week, the price has changed by +0.23%, over one month by +0.45%, over three months by +6.88% and over the past year by +18.63%.
Is FVAL a buy, sell or hold?
What are the forecasts/targets for the FVAL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 87.2 | 17.9% |
FVAL Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.13b USD (1.13b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.13b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.13b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.33% (E(1.13b)/V(1.13b) * Re(9.33%) + (debt-free company))
Discount Rate = 9.33% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)